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Xenoestrogens from synthetic or natural origin represent an increasing risk of disrupted endocrine
functions including the physiological activity of the hypothalamo-pituitary-gonad axis. Ethinyl estra-
diol (EE2) is a synthetic estrogen used in contraceptive pills, whereas zearalenone (ZEA) is a natural
mycoestrogen foundwith increasingprevalence in various cereal crops. BothEE2andZEAareagonists
of estrogen receptor- and accelerate puberty. However, the neuroendocrine mechanisms that are
responsible for this effect remain unknown. Immature female Wistar rats were treated with EE2 (10
g/kg), ZEA (10mg/kg), or vehicle for 10 days starting from postnatal day 18. As amarker of puberty,
thevaginalopeningwasrecordedandneuropeptideandrelatedtranscriptionfactormRNAlevelswere
measured by quantitative real time PCR and in situ hybridization histochemistry. Both ZEA and EE2
accelerated thevaginalopening, increased theuterineweightand thenumberofantral follicles in the
ovary, and resulted in the increasedcentral expressionofgnrh. These changesoccurred inparallelwith
anearlier increaseofkiss1mRNAin theanteroventral and rostralperiventricularhypothalamusandan
increasedkisspeptin(KP)fiberdensityandKP-GnRHappositions inthepreopticarea.Thesechangesare
compatiblewithamechanisminwhichxenoestrogensoverstimulatethedevelopmentallyunprepared
reproductive system,which results in an advanced vaginal opening and an enlargement of the uterus
at the periphery. Within the hypothalamus, ZEA and EE2 directly activate anteroventral and periven-
tricularKPneuronstostimulateGnRHmRNA.However,GnRHandgonadotropinreleaseandovulation
are disrupted due to xenoestrogen-mediated inhibitory KP signaling in the arcuate nucleus.
(Endocrinology 156: 0000–0000, 2015)
Xenoestrogens are synthetic or naturally occurring es-trogenmimetic compounds that have been implicated
in precocious puberty and a variety of other reproductive
anomalies. However, their neuroendocrine mechanisms
of actions are not fully understood.
Zearalenone (ZEA) is an estrogenic mycotoxin pro-
duced by several Fusarium species (1). ZEA is found
worldwide in livestock feed and human food made from
cereal crops such as maize, barley, oats, and rice (2). In
food, ZEA contamination may reach a level that disrupts
endocrine/reproductive functions (3).
The estrogenic effect ofZEAand itsmetabolites,- and
-zearalenol, has been verified in silico (4, 5), in vitro (6),
and in vivo (7, 8). Due to similarities in the molecular
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structure of ZEA and 17-estradiol, ZEA has the capa-
bility to bind to the ligand-binding pocket of the estrogen
receptor (ER) and stabilize at least one of the functionally
active conformations of the receptor’s ligand binding do-
main (5). ZEA preferentially activates ER and displays
partial antagonist activity on ER, especially at high con-
centrations (9, 10).
Depending on the developmental timing of mycotoxin
exposure, ZEA has multiple adverse effects on female re-
production (11) including enlargement of the uterus (7, 8),
persistent anovulatory cycles (12, 13), decreased fertility,
and defective embryonic implantation and development
(14).
It has been repeatedly shown that ZEA administration
accelerates the puberty onset in mice (13, 15) and rats (8)
but not in gilts (11, 12, 16).
Sporadic epidemics of precocious puberty in human
females were attributed to exposure of anabolic estrogens
in animal foods such asZEA in Italy (17), PuertoRico (18,
19), and Hungary (20). However, the neuroendocrine
mechanism through which estrogenic mycotoxins accel-
erate puberty onset remains to be elucidated.
Ethinyl estradiol (EE2) is the major estrogenic compo-
nent of contraceptive pills, which are often taken at
peripubertal ages.EE2 is alsoprescribed toalleviatemeno-
pausal symptoms, used as palliative therapy in malignant
tumors of breast and prostate cancer, and also applied as
steroid substitution to girls with Turner syndrome. Unin-
tended EE2 exposure may also originate from the envi-
ronment, in which significant amounts of EE2 have been
detected due to the urine and feces of women taking the
contraceptive pill. An additional load may originate from
livestock and aquaculture (21, 22). EE2 andZEAare both
ER ligands. Previous in vivo studies have shown that EE2
and ZEA elicit similar effects on the timing of puberty,
although ZEA has a lower efficacy and a 1000-fold lower
potency than EE2 (6, 23). Increasing evidence indicating
that exposure to different estrogenic compounds results in
compound-specific effects onmorphological, histological,
and molecular level (24, 25) led us to study and compare
neuroendocrine mechanisms that are responsible for ad-
vanced puberty in rats treated with EE2 and ZEA.
Kisspeptin (KP) and its receptor, G protein-coupled re-
ceptor 54 (GPR54) (kisspeptin-1 receptor) have been im-
plicated in initiation of puberty and regulation of the hy-
pothalamo-pituitary-gonad (HPG) axis through GnRH
synthesis and release (26–29). KP is synthesized by two
distinct groups of hypothalamic neurons in the antero-
ventral periventricular (AVPV) and arcuate (ARC) nuclei,
respectively (30, 31). KP is a potent GnRH secretagogue,
results in depolarization of GnRH neurons, and advances
puberty in mice (28). By contrast, mutations of the gpr54
gene are associated with impaired sexual maturation in
mice and humans (32, 33). Furthermore, GnRH-specific
gpr54 knockout results in delayed puberty onset, abnor-
mal estrus cycles, and infertility (34, 35).
Most KP neurons express ER, which plays a funda-
mental role in mediation of steroid feedback on the HPG
axis (36–38). The twoKP neuron populations display dif-
ferential responsiveness to estrogens becausekiss1 expres-
sion is stimulated by 17-estradiol in the AVPV but in-
hibited in the ARC (39, 40). Furthermore, studies onmice
with conditional knockout of the ER gene from kisspep-
tin neurons revealed that estrogen-responsive KP cells in
the arcuate nucleus restrain the HPG axis and delay pu-
berty onset in juvenile animals, whereas subsequent ER-
dependent activationofGnRHneuronsdependsonAVPV
KP input, which accelerates gonadal, hormonal, and sex-
ual maturation during puberty (41). Recent findings sug-
gest that puberty occurs when kiss1 in the ARC is relieved
from the suppression mediated by the polycomb group of
transcription silencing complexes before puberty (42).
Furthermore, the expression of makorin3 (mkrn3), which
encodes a transcriptional suppressor protein with a really
interesting new gene (RING) finger domain, also declines
in the mouse hypothalamus just before puberty (43).
There is increasing evidence for a correlation between
body levels of estrogenic endocrine disruptor compounds
and precocious puberty in girls. For instance, urinary bi-
sphenol levels were significantly higher in girls with idio-
pathic central precocious puberty (44). Recently the asso-
ciation of phthalate exposure, kisspeptin plasma levels,
and precocious puberty has been revealed (45). We hy-
pothesized that the endocrine disruptor effect of the xe-
noestrogensZEAandEE2 ismediated throughkisspeptin-
kisspeptin-1 receptor signaling in the hypothalamus. To
address this issue, female prepubertal Wistar rats were
exposed to ZEA, (an estrogenic mycotoxin) or EE2, (a
prototype of estrogenic disruptor compounds), and the
physiological and hormonal responses were analyzed to-
getherwith changes in kisspeptinergic signaling onGnRH
neurons. Both EE2 and ZEA advanced puberty onset in
females. This was accompanied by selective increase of
kiss1 and gnrh mRNA expression in the anterior hypo-
thalamus, without noticeable changes of kisspeptin sig-
naling in the ARC. These results identify kisspeptin-
GPR54 signaling as a central target of the endocrine
disruptor effect of EE2 and the ZEA.
Materials and Methods
Animals
Female Wistar rats (n  40) from the colony bred at the
Institute of Experimental Medicine (Budapest, Hungary) were
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used. Animals were kept at theminimal disease (MD) level of the
institute’s animal facility under standard conditions (tempera-
ture 22°C  3°C; relative humidity 30%–70%; lighting 12 h
light, 12 h dark cycle; lights on at 7:00 AM). Animals had free
access to phytoestrogen-free rodent diet (Harlan Teklad Global
Diets) and tapwater. Ratswereweaned,weighed, and randomly
allocated to treatment groups at postnatal day (PND) 18. All
procedureswere conducted in accordancewith the guidelines set
by the European Communities Council Directive (86/609 EEC)
and approved by the Institutional Animal Care and Use Com-
mittee of the Institute of Experimental Medicine (permit num-
bers PEI/001/35-4/2013 and PEI/ 001/29-4/2013).
Treatment and processing
Ratswere treatedwith EE2 (Sigma; 10g/kg bodyweight) or
ZEA (Sigma; 10 mg/kg body weight [bw]) for 10 consecutive
days, starting at PND 18 according to the protocol used for the
immature rat uterotrophic assay developed and validated by
the Organisation for Economic Co-operation and Develop-
ment (protocol number 440, http://www.epa.gov/endo/pubs/
uterotrophic_oecd_guideline.pdf). The dose of the ZEA was
based on our previous study (8), whereas the dose of EE2 was
selected in a pilot uterotrophic assay (Supplemental Figure 1).
EE2 and ZEA were dissolved first in alcohol and then diluted in
olive oil at a ratio of 1% ethanol and 99% oil. The vehicle was
also prepared with the same ratio. Drugs and vehicle were ad-
ministered daily by oral gavage (1mL/kg bw), between 9:00 and
11:00 AM. For each animal, individual doses were calculated
daily, after measurement of the body weight. Based on the dose-
response studies, in the main experiment, the following groups
were used: 10 g/kg bw EE2 (n  14), 10 mg/kg bw ZEA (n 
11), and the vehicle oil (control, n  15). Rats were randomly
assigned to treatment groups. Animals were housed in groups of
four to five per cage during treatment, and the sequence of the
treatments varied day by day. The weight of animals and food
andwater consumptionweremeasured, and the vaginal opening
was examined daily, before gavage.
On PND 28, vaginal smears were taken, and then the rats
were killed by decapitation, and trunk blood was collected for
hormone measurement. The brain was rapidly removed from
the skull, placed into acrylic coronal matrix, and dissected to
isolate an AVPV/preoptic area (POA)-enriched region and an
ARC-enriched region (see Figure 3). Viewing from the ventral
surface of the brain, a series of three cuts in the coronal plane
were made using a sterile razor blade: the first cut was placed
2 mm in front of the optic chiasm, the second one at the apex
of the pituitary stalk, and the third one at the rostral margin
of the mammillary bodies. This sectioning resulted in two
hypothalamic slabs that were placed flat facing to the plane of
the second cut. AVPV/POA regions were dissected from the
first slab by two sagittal cuts 2 mm from the midline and one
horizontal cut just above the third ventricle. ARC-enriched
samples were prepared from the second slab by placing two
sagittal cuts on either side of the optic tract and a horizontal
cut through the middle of the third ventricle. To control the
amount of tissue dissected per rats, and thus entering the re-
verse transcription reaction, hypothalamic tissue samples
were weighed. No significant differences in the weight of hy-
pothalamic tissue samples were observed between compara-
ble experimental groups. Dissected tissue samples were im-
mediately frozen on dry ice and stored at 70°C until assay.
At autopsy, ovaries and the uterus were also removed,
weighed, and immersion fixed in 10%buffered formalin. Tissue
samples were embedded in paraffin, sectioned (10 m), and
stained with hematoxylin-eosin. All microscopic analyses were
performed blind to the identification of any group.
RNA isolation and quantitative RT-PCR
For total RNA isolation, hypothalamic blocks were homog-
enized in 500LTRI reagent (Ambion). TotalRNAwas isolated
using a total RNA minikit (Geneaid) according to the manufac-
turer’s instructions. To eliminate genomic DNA contamination,
deoxyribonuclease I treatmentwas introduced (1U per reaction,
reaction volume 50 L ribonuclease-free deoxyribonuclease I;
Fermentas). Sample quality control and the quantitative analysis
were carried out by NanoDrop (Thermo Scientific). cDNA syn-
thesis was performedwith the high-capacity cDNA reverse tran-
scription kit (Life Technologies) according to themanufacturer’s
instructions.
The chosen primer sequences used for the comparative cycle
threshold experiments were verifiedwith the Primer Express 3.0 pro-
gram.The sequenceswere as follows:gnrh, forward,CCCCAAACT-
GATGGCCGCTGTT, reverse, AGGGCGCAACCCATAGGA
CCA; kiss1, forward, CACCTGTGGTGAACCCTGAAC, reverse,
CAGGCTTGCTCTCTGCATACC; gpr54, forward, TGCAGAC-
CGTCACCAATTTC, reverse, TGAAGGGTACGCAGCACAGA;
gapdh, forward, ACAGCCGCATCTTCTTGTGC, reverse, GCCT-
CACCCCATTTGATGTT; nkb, forward, CTAGCGTGGGA
CCGAAGGA, reverse, GCCCATAAGTCCCACAAAGAAGT;
dyn, forward, GAATCTGAGCTACTGGGCACTGA, reverse,
TTTCTCAAGTCCTCCTCGTTGAA; th, forward, AGTA-
CAAGCACGGTGAACCA, reverse, GATGCTGTCCTCTCGG-
TAGC; eap1, forward, CTACGAGGTGCGCTTCAAGA, reverse,
CTTAGAGACCGCGTCGAAGG; ttf1 (nkx2), forward,
CGGGCAAGATGTAGGCTTCTA, reverse, CATGATTCG-
GCGTCGGCTTAAC; mkrn3, forward, GCTCCGCAATT
CAAGCACAA, reverse, AGCGTGCCTCTAACACTGTC; cux1,
forward, GAAAGGCCGAGAACCCTTCA, reverse, TGGTCCTT-
GTTGTTGCCCTT; eed, forward, GAACAGCAACCCGGAC-
CTCTCG, reverse, TTCCCTTTCCCCAGCTTTTCCTTC; cbx7,
forward, GACGCCCATGCTCCCCTCAAGT, reverse, CCTCAC-
CCAAGCCCCAAGAAACAC; er, forward, CCGCCTTCTA-
CAGGTCCAAT, reverse, GAAAGCCTTGCAGCCTTCAC; and
er, forward, GTTGTGCCAGCCCTGTTACTAGTC, reverse,
GGTACACTGATTCGTGGCTGGACAGATATA.
The primers (Invitrogen) were used in a real-time PCRwith a
FastEvaGreenquantitative PCRmastermix (Biotium)onanABI
StepOnePlus instrument (Applied Biosystems). The gene expres-
sion was analyzed using the ABI StepOne 2.1 program (Applied
Biosystems).Theampliconswere testedbymelt curveanalysis on
an ABI StepOnePlus instrument (Applied Biosystems). Experi-
ments were normalized to gapdh expression.
Perfusion and tissue processing for in situ
hybridization histochemistry and
immunocytochemistry
Another set of vehicle-, ZEA-, and EE2-treated rats (n 16)
was deeply anesthetized on PND 28 with pentobarbital (100
mg/kg, ip) and perfused through the ascending aorta with saline
followed by ice-cold fixative (4% paraformaldehyde in 0.1M
Borate buffer [pH 8]). Brains were postfixed in the fixative for 3
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hours and then placed in 0.1 M potassium PBS containing 10%
sucrose overnight. A series of 30-mfrontal sectionswere cut on
a freezing microtome, collected in a cryoprotectant, and stored
at 20°C until processing.
In situ hybridization histochemistry
Antisense complementary RNA (cRNA) probes labeled by
35S-uridine triphosphate (DuPont NEN) were used throughout.
The kisspeptin probe was transcribed from a 411-bp mouse
cDNA template (bases 76–486 of AF472576) subcloned into
pGEMTEasy. The plasmid was linearized by Sac1 and used as
template for in vitro RNA transcription using T7 RNA
polymerase.
The probe for GPR54 in situ hybridization histochemistry
wasproduced inour laboratoryusing rat hypothalamic cDNAas
a template to generate a gpr54-specific PCR fragment. The PCR
was carried out using gpr54 forward and T7 gpr54 antisense
primers. The amplicon was visualized by gel electrophoresis
(1.8% agarose gel, 0.5  Tris-borate EDTA buffer), and the
gpr54-specific PCR product (473 bp) was isolated from the gel
(gel/PCR DNA fragment extraction kit; Genaid). This fragment
(10 ng) was served as a template to a second PCR to increase the
specificity of the gpr54 amplicon. The second PCR was carried
out using T7 and gpr54 forward primers, and the PCR product
was visualized and isolated as above. Details of the PCRs and
primer sequences are described in the Supplemental Methods.
The amplicon (50 ng) served as a template for in vitro radionu-
clide (35S-uridine 5-triphosphate; DuPont NEN)-labeled cRNA
probe synthesis using T7RNApolymerase. The specificity of the
designed primers was verified by Primer Blast software.
Hybridization and autoradiographic procedures were mod-
ified following those of Simmons et al (46). Tissue sections were
mounted onto SuperFrost Ultra Plus slides (Menzer-Glazer
Braunschweig) postfixed with 4% paraformaldehyde, digested
with Proteinase K (10 g/mL in 50 mM Tris [pH 8] and 5 mM
EDTA [pH 8] at 37°C for 10 min), acetylated (0.25% acetic
anhydride in 0.1 M triethanolamine [pH 8]), and dehydrated.
Hybridization mixture (50% formamide, 0.3 M NaCl, 10 mM
Tris [pH 8], 2 mMEDTA, 1Denhardt’s, 10%dextran sulfate,
0.5 mg/mL yeast tRNA, and 10 mM dithiothreitol [DTT]) was
pipetted onto the slides (100 L, containing probe at 107 dpm/
mL) and hybridized overnight at 56°C. Sectionswere then rinsed
in 4 saline sodium citrate [SSC] (1 SSC: 0.15MNaCl and 15
mMtrisodium citrate buffer, [pH7]), digestedwith ribonuclease
A (20 g/mL in Tris-EDTA buffer with 0.5 MNaCl at 37°C for
30min), graduallydesalted in2SSC-1SSC-0.5SSCallwith
1 mMDTT for 5 minutes each, and washed in 0.1 SSC with 1
mM DTT at 65°C–75°C for 30 minutes and dehydrated in al-
cohols. Slides were exposed to Phosphoimager image plates for
24–48 hours and then dipped in nitroblue tetrazolium salt nu-
clear emulsion (Kodak) and exposed for 2–3weeks, developed in
D-19 developer, and lightly counterstained with cresyl violet.
Densitometric analysis of the in situ hybridization histochemis-
try was performed using the advanced Image Data Analyzer
(AIDA version 3.1) software on scanned images obtained by the
BASReader program (Raytest IsotopenmessegerateGmbH).An-
atomical regionsof interestwere identifiedusinga rat brain atlas.
The density measurement was corrected by subtraction of a
background value obtained from a neighboring nonhybridized
tissue area from the same section.
Double immunofluorescence for GnRH and
kisspeptin immunoreactivity
To evaluate changes in KP fiber density and kisspeptinergic
inputs to GnRH neurons, double-labeling immunofluorescence
was performed. After blocking in 2% normal goat and donkey
serum, free-floating sections were incubated in a mixture of
guinea pig anti-GnRH (number 1018Hrabovszky, 1:3000 [47])
and rabbit anti-KP (number 566, Caraty, 1:10 000 [48]) over-
night at 4°C. The antigens were then visualized by biotinylated
goat antiguinea pig IgG (Vector Labs; dilution 1:500) for 1 hour
followed by streptavidinALEXA350 (Molecular Probes; 1:500)
and donkey antirabbit ALEXA 488 (Molecular Probes; 1:500)
for 3 hours. After PBS washing, the sections were mounted onto
chrome-alum gelatin-coated slides and coverslipped with Pro-
Long Gold antifade reagent (Life Technologies).
Confocal microscopic analysis
Confocal imaging was performed on Olympus FluoView
FV1000 (Olympus) laser-scanning confocal microscope using
100/1.45 oil objective. All image acquisition and quantifica-
tion was performed by an individual blind to the treatment con-
ditions. Images were consistently collected at, but not past, the
threshold of overexposure to standardize analysis parameters
across image stacks. KP fiber projections toGnRHneuronswere
evaluated at the rostral POA by using z-stack imaging. Three-
dimensional image analysis was carried out by using Imaris soft-
ware (Bitplane). From each animal, nine GnRH neurons were
selected in the double-immunostained (GnRH and KP) material
using the following criteria: 1) the cell had definitive GnRH im-
munoreactivity, 2) the total plane of the somawas visible within
the z-stack,3)hadadefinednucleus, and4) sufficiently separated
from other cells to clearly identify kisspeptin fiber appositions.
The GnRH neurons were identified by slowly scrolling through
the z-plane. To quantify the number of GnRH/KP appositions,
we counted the total number of immunoreactive boutons in ap-
position to the soma through the complete z axis of each of the
nine cells. These appositions were defined by visualizing no vis-
ible space between KP-immunoreactive profiles and the GnRH
cell membrane.
GnRH/KP double-stained hypothalamic sections have been
used to quantify KP fiber density in the preoptic area. The region
of interest has been selectedby revealingGnRH-immunoreactive
cells, and the density ofKP-immunoreactive fiberswere analyzed
after thresholding in ImageJ software (National Institutes of
Health, Bethesda, Maryland). In this analysis the data represent
the area occupiedby immunolabeled fibers as a proportionof the
total region of interest area but not the specific number of fibers.
Hormone measurement
After decapitation, trunk blood was collected into ice-cold
EDTA-containing tubes, centrifuged, and plasma samples were
then stored at 20°C until assay. Plasma hormone levels were
measuredby enzyme immunoassay (EIA) kits obtained fromNo-
vaTec Immunodiagnostica GmBH, according to the manufac-
turer’s instructions. 17--Estradiol EIA kit (catalog number
DNOV003; assay range 0–2000 pg/mL; sensitivity 5 pg/mL;
accuracy 96.5%  3.1%; intra- and interassay coefficients of
variations are 3.2% and 5.4%, respectively). The assay showed
less than 0.001% cross-reactivity with ZEA. The lowest detect-
able concentrationsofFSH(catalognumberDNOV031)andLH
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(catalog number DNOV030) EIA kits are 0.6 and 0.5 mIU/mL,
respectively). The measured values were transformed to pico-
grams per milliliter in the case of LH and FSH.
Statistical analysis
The results are shown as means  SEM. Data were assessed
for normality and homogeneity of variances by Kolgomorov-
Smirnov tests and then analyzed by a one-way ANOVA (Graph-
Pad Prism) followed by Bonferroni’s or Tukey post hoc tests. In
case of data showing non-Gaussian distribution, the Mann-
Whitney U test was used. Body weight data were analyzed with
a repeated-measure ANOVA, time being the repeated measure.
In all cases, differenceswere considered statistically significant at
P  .05.
Results
Vaginal opening: onset of puberty
Both ZEA and EE2 advanced puberty as measured by
the number of rats showing vaginal opening, an external
sign of puberty onset.Onehundredpercent of rats showed
a vaginal opening at PND 24 or PND 25 in case of EE2-
or ZEA-treated rats, respectively. None of the vehicle-
treated control animals displayedavaginal openingbefore
the end of the experiment at PND 28
(Figure 1A). Vaginal opening in the
naïve group occurred at PND30–31
(Supplemental Figure 1).
Vaginal smears taken at the endof
the experiment (PND 28) revealed
that 62.5% of ZEA-treated rats
showed proestrous-like, 12.5% es-
trous-like, and 25% metestrous-like
smears. Among the rats treated with
EE2 for 10 days, on the basis of vag-
inal smears, 37.5% were in proes-
trus, 37.5% in estrus, and 25% in
metestrus.
Ten-dayZEAandEE2 treatment re-
sultedinasignificantenlargementoftheuterus(F[2.26]35,10,
P  .0001) compared with controls. The normalized uterus
weight of ZEA- or EE2-treated animals were 2.16-fold and
2.34-foldhigher, respectively, than those of vehicle-treated rats
(Figure 1B).
Histological analysis of the hematoxylin-eosin stained
ovarian sections revealed a large number of small antral
follicles in ZEA- and EE2-treated animals. No corpora
luteawere observed in the xenoestrogen-treated rats (Sup-
plemental Figure 2).
Because the timingof puberty dependson themetabolic
resources of the animals, we checked whether xenoestro-
gen treatment affected body weight. Repeated-measures
ANOVAondaily bodyweight data andone-wayANOVA
oncumulative bodyweight gaindata revealed a significant
effect of treatment (F[2.37]  10.58, P  .0002). Bonfer-
roni’s post hoc test indicated that EE2-treated premature
female rats gained significantly less body weight during
the treatment period (PND 18–28) than vehicle- or ZEA-
treated animals (Figure 2, A and B). Daily and cumulative
food and water intake of the three groups were not sig-
nificantly different (Supplemental Figure 3).
Xenoestrogens increase gnrh
expression in the hypothalamus
Next,weinvestigatedtheeffectofxe-
noestrogensongnrhmRNAlevelsinthe
hypothalamus.gnrhexpressionwassig-
nificantly increased after EE2 or ZEA
treatmentasmeasuredbyaquantitative
PCR from AVPV/POA-enriched brain
tissues (P  .0012 for both xenoestro-
gens by a Mann-Whitney U nonpara-
metric test) relative to vehicle-treated
rats. ZEA and EE2 treatments resulted
in 2.52-fold and 3.65-fold increases, re-
spectively (Figure 3B).
Figure 1. Effect of xenoestrogens on the vaginal opening and uterus weig. A, Percentage of
rats displaying a vaginal opening after ZEA or EE2 treatment. None of the vehicle-treated control
animals had a vaginal opening until the end of the experiment (PND 28). B, The mean  SEM
values of the uterine weights normalized to body weight.
Figure 2. Effect of xenosestrogens on body weight. Mean  SEM values of daily body weights
(A) and cumulative weight gain (B) in vehicle-treated controls, ZEA- (10 mg/kg), and EE2 (10 g/
kg)-treated immature female rats are show (n  38). The treatment started at PND18. ***, P 
0,001.
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ZEA and EE2 differentially affect kiss1 and gpr54
mRNA levels in the hypothalamus
Aperipubertalincreaseofgnrh isattributable,atleastinpart,
to estrogen-sensitive inputs to the GnRH neurons. Among
these,kisspeptinergicinnervationplaysapivotalroleinpubertal
timing. Because kiss1 expression is regulated reciprocally by
estrogen in the AVPV/rostral periventricular (PeV) and ARC
regions in the rodentbrain,kiss1andkisspeptin receptorgpr54
mRNA levels were measured in these brain areas separately.
Both ZEA and EE2 treatment resulted in a significant increase
inkiss1 expression in theAVPV/PeV (ZEA:2.83-fold increase;
EE2:2.82-foldincrease),whereasintheARCregion,significant
alterationswere not observed (Figure 3,C andD). The expres-
sion of gpr54 increased significantly only in the ARC (ZEA:
1.68-fold increase; EE2: 1.89-fold increase, Figure 3, E and F).
Within thearcuateblock, therelativequantityofneurokinin
B (nkb) mRNA levels decreased in ZEA- and EE2-treated rats
(F[2.11] 6.71; P .013). However, the expression of dynor-
phin (dyn) did not differ in xenoestrogen-treated animals com-
paredwith thevehicle-treatedcontrols (F[2.12]0.17;P .84)
(Figure 4).
No changes were detected in the hypothalamic mRNA
levels of ERs er (F[2.10] 2.77; P .11) or er (F[2.10]
1.27; P  .30 not shown).
RING finger transcription factor makorin 3 (mkrn3) has
been implicated in sexual development as a break of puberty
(49).Mkrn3mRNAwaselevatedexclusively in theAVPV/PeV
after the EE2 treatment (Supplemental Figure 4). A small in-
creaseinthemRNAlevelofeedwasalsodetectedintheanterior
hypothalamic block (Supplemental Fig-
ure 4). The relative quantities of cbx7,
cux1,eap1, and ttf1 transcriptionfactor
mRNA remained unaltered in ZEA-
and EE2-treated animals compared
withvehiclecontrols(SupplementalFig-
ures 5 and 6).
In situ hybridization
histochemical localization of
kiss1 and gpr54 mRNA
In vehicle-treated female rats, we
found kiss1 in situ hybridization sig-
nals exclusively over the neurons in
the AVPV, the rostral PeV, and the
Figure 3. Effect of xenoestrogens on hypothalamic neuropeptide expression. A, Depiction of the cuts made to separate anterior and posterior
hypothalamic blocks. B and C, Mean relative quantities of GnRH (gnrh) (B); KP (kiss1) (C and D) and KP receptor gpr54 (E and F) mRNA in the
anterior (AVPV/POA) (B, C, and E) and posterior (ARC) (D and F) hypothalamic blocks. FC, fold change compared with gapdh-normalized value of
vehicle-treated rats. *, P  .05; **; P  .01; ***, P  .0005.
Figure 4. Effect of xenoestrogens on neurokinin B (nkb) and dynorphin (dyn) expression in the
arcuate region. Fold change (mean  SEM) values of ZEA- and EE2-treated animals compared
with vehicle-treated controls are shown.
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ARC nuclei. In response to ZEA or EE2 administration,
increased KP mRNA expression was revealed in the
AVPV/PeV (Figure 5), without detectable changes in the
ARC. Extrahypothalamic expression of kiss1was not de-
tected after the xenoestrogen treatment.
35S-uridine 5-triphosphate-labeled riboprobes corre-
sponding togpr54mRNArevealeda specific patternofKP
receptor expression in the rat brain. In vehicle-treated an-
imals, intense hybridization signals were detected in the
cortical layers as well as in the CA1–4 areas and the den-
tate gyrus of the hippocampal formation. Strong labeling
corresponding to gpr54 mRNA has been revealed in the
lateral habenula, in the subfornical organ, bed nucleus of
stria terminalis, and the mammillary region. Within the
hypothalamus, the POA, suprachiasmatic, supraoptic,
caudal paraventricular, ventromedial, and ARC nuclei
were moderately labeled. In response to ZEA and EE2,
there was a selective increase in the intensity of the hy-
bridization signal in the medial basal hypothalamus (Fig-
ure 5). The strength and distribution of the hybridization
signal at the extrahypothalamic areas also remained un-
changed after ZEA and EE2 treatment (data not shown).
Endocrine disruptors increase KP fiber density in
the preoptic area and the number of KP
appositions onto GnRH neurons
Analysis of immunofluorescentmaterial revealed an in-
creased density of KP-immunoreactive fibers in the pre-
optic region of ZEA- and EE2-treated animals. One-way
ANOVA revealed a significant treatment effect (F[2.6] 
5.65, P .042). Treatment with the endocrine disruptors
resulted in 5-fold and 8-fold increases in the KP fiber den-
sity in the case of ZEA and EE2, respectively (F[2.15] 
12.06, P  .0008) (Figure 6).
Furthermore, using double-labeled immunfluores-
cence, we revealed KP fibers in close apposition to GnRH
neurons in the POA. Specifically, the number of KP ap-
positions onGnRHneuronswas significantly increased in
Figure 5. Effects of xenoestrogens on kiss1 and gpr54 mRNA signals
in the hypothalamus. Representative dark-field autoradiograms
showing signals obtained after in situ hybridization with cRNA probes.
Top row, kiss1 mRNA in the anterior periventricular region. Bottom
row, gpr54 mRNA signals in the ARC after the vehicle, ZEA, or EE2
treatments. Photomicrograph magnification, 75.
Figure 6. Changes in GnRH and kisspeptin immunostaining in the POA of xenoestrogen-treated prepubertal female rats. Top panels,
Representative fluorescence images showing double labeling for GnRH (blue) and kisspeptin (green) in the POA of the vehicle-treated control (A),
ZEA-treated (B), and EE2-treated (C) female rats. Bottom panels, Schematic drawing depicting the rostral POA as the region of interest for the
quantitative analysis of KP-immunoreactive fibers (D). The density of the KP-immunoreactive fibers in the POA (E) and the number of
kisspeptinergic profiles in close apposition with GnRH-immunoreactive neurons (F) in control, ZEA-, and EE2-treated female rats is shown.
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the EE2- and ZEA-treated animals (F[2.24]  9.5; P 
.0009) (Figure 6).
Effect of ZEA on plasma hormone levels
Plasma LH (F[2.11]  0.90, P  .42) and FSH (F[2.9] 
0.14, P .87) concentrations did not change significantly
after ZEA or EE2 treatment. EE2, but not ZEA, admin-
istration significantly reduced the 17-estradiol concen-
tration (F[2.12] 8.01, P .006) by the end of the 10-day
administration period (Figure 7).
Discussion
This study shows that administration of two xenoestro-
gens, the synthetic estrogen derivative EE2 and the non-
steroidal mycoestrogen ZEA, to sexually immature pre-
pubertal female rats advances puberty, which is paralleled
by increases in KP signaling to GnRH neurons and in-
creased gnrh expression. The effect of xenoestrogens on
KP neurons is site and gene specific because 10 days of
ZEA or EE2 administration elevated kiss1 mRNA levels
exclusively in the AVPV/PeV but not in the ARC region.
Previous experiments on laboratory rodents and do-
mestic animals, and studies on mycotoxin exposed hu-
mans, have established the endocrine-disruptive and pu-
berty-accelerating effects of ZEA. In this study on rats, we
have used the time of vaginal opening as the first pheno-
typic marker of puberty onset in ro-
dents, although the central and pe-
ripheral mechanisms that contribute
to this process are not fully under-
stood. It should also be noted that ac-
celerated vaginal opening does not
necessarily indicate onset of normal
estrous cycles, and there are examples
when the timing of vaginal opening
andmaturation of central neuroendo-
crine circuits are not correlated (50,
51). It is very likely that in addition to
their central effects, xenoestrogens
may directly stimulate peripheral es-
trogen-sensitive tissues such as the va-
gina and uterus to produce morpho-
logical and histological changes seen
in puberty.
We foundZEA- and EE2-induced
accelerated vaginal opening to be ac-
companied by significant increases
in gnrh mRNA levels in the anterior
hypothalamus. Indeed, stimulation
of gnrh gene expression is the rate-
limiting factor for the onset of pu-
berty (52), although GnRH neurons are not directly re-
sponsive to the positive feedforward effects of estrogens
that initiate sexual maturation.
Among the neurotransmitters and neuropeptides that
regulate GnRH neurons, KPs and other RFamide-related
peptides have been implicated in themediationof estrogen
effects and the progression of puberty. Most KP neurons
express ER (41, 48), and kisspeptinergic fibers have been
identified to form synaptic contacts with GnRH neurons
(53, 54) that possess GPR54, the KP receptor (29, 55).
Furthermore, KP alters the electrophysiology and activa-
tion of GnRH neurons (56, 57). Sex steroids play a prom-
inent role in driving morphological and functional plas-
ticity of the hypothalamic KP system during puberty (40).
During pubertal maturation, there is a significant increase
in KP content and the number of contacts betweenKP and
GnRH neurons (58). ZEA and EE2 elevated the KP fiber
density in the anterior hypothalamus, and the number of
KP appositions on GnRH neurons was also increased.
Although these contacts have not been confirmed by high-
resolution microscopy, the light microscopic morpholog-
ical rearrangements seen after ZEA and EE2 administra-
tion are compatiblewith increasedkisspeptinergic drive to
GnRH neurons similar to that seen in normal puberty.
During normal puberty, there is a shift from the inhibition
to stimulation of GnRH neurons via changes in kisspep-
tinergic signaling. Based on our present data, ZEA and
Figure 7. Plasma hormone levels after xenoestrogen treatment. Mean  SEM values of plasma
LH, FSH, and 17-estradiol levels in vehicle- (control), ZEA-, and EE2-treated prepubertal rats
(n  10–12). **, P  .01.
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EE2 stimulate GnRH expression via the activation of the
AVPV KP drive. However, GnRH release and subsequent
gonadotropin release is blocked by an excess of
xenoestrogens.
One concernmight be the specificity of theKPantibody
because many of these antibodies cross-react with other
members of RFRPs. Indeed, there are some mismatches
between staining patterns generated by two N-terminal
antibodies vs the C-terminal-specific antibody (AC566)
used in this experiment (Table 1). However, KP staining
remains after preabsorption with the RFRP antibody,
whereas it is completely absent in KP knockout mice (59).
In addition to morphological changes in kisspeptiner-
gic neurocircuits,wehave revealed a significant increase in
the kiss1mRNA levels in the hypothalamus after 10 days’
administration of endocrine disruptor compounds. Of
note, our data revealed site-specific effects of ZEA and
EE2 on kisspeptin expression in the AVPV region, which
is compatiblewith thepositive feedback effect of estrogens
onKP synthesis in this region.An estrogen-mediated grad-
ual increase of KP peptide expression is necessary for pu-
berty onset (60). It is intriguing thatZEAorEE2 treatment
in the prepubertal period had no effect on kiss1 mRNA
levels in the arcuate nucleus.
The molecular mechanisms through which estrogenic
compounds produce opposite effects on kiss1 transcrip-
tion at AVPV and ARC remain to be fully explored. Pre-
vious studies indicated that estrogen-induced kiss1 ex-
pression in the AVPV requires an ER-DNA interaction,
whereas the inhibition of KP mRNA levels in the ARC
occurs through a nongenomic action or other ERE-inde-
pendent effects of estrogens. ZEA and EE2 might also
increase kiss1 transcription in the AVPV through the clas-
sical nuclear estrogen-response element-mediated path-
way. In support of this, it hasbeen shown invitro thatZEA
had strong estrogenic effects due to its ability to activate
both activation function-1 andactivation function-2 func-
tions (61).
As yet, the potential contribution of such differential
signaling to the developmental actions of xenoestrogens
has not been studied in detail and will merit specific in-
vestigation. This differential regulatory pathway may ex-
plain the different sensitivity of KP neurons to the normal
organizing effects of sex steroids indifferent hypothalamic
nuclei; AVPV neurons display a higher degree of sexual
dimorphism than ARC neurons in rodents (30). In addi-
tion, recognition of this divergent regulatory mechanism
may help to define the different modes of actions of es-
trogens and xenoestrogens on KP neurons, which may
involve nonclassical ER pathways as well as ER-indepen-
dent mechanisms, in line with emerging data in other tar-
get tissues of endocrine disruptors. It should be added,
however, that long-term treatment with ZEA or EE2 did
not alter ER/ER mRNA levels in the hypothalamus.
Another possibility for the differential effect of these xe-
noestrogens on KP neuron populations would be differ-
ential recruitment of steroid receptor coactivators or core-
pressors in the AVPV vs ARC.
Two critical periods have been identified during the
sexual development in which rodents are specifically vul-
nerable to endogenous and exogenous estrogenic com-
pounds including endocrine disruptors: the perinatal and
theperipubertal age (62). Prenatal, neonatal, or earlypost-
natal exposure of natural, synthetic, or phyto/xenoestro-
gens can have both feminizing and defeminizing effects on
the developing neural mechanisms that control sexual be-
havior (63). KPneurons are especially sensitive to both the
early organizing and the acute regulatory actions of es-
trogens (62). These organizational steroid actions cause
reduced kisspeptin transcription and cell numbers in the
AVPV and KP inputs to GnRH neurons in adults. For
instance, female rats exposed in utero (gestational d 6–21)
to EE2 were heavier and had delayed vaginal opening,
aberrant estrous cyclicity, and masculinized behavior
(64). By contrast, upon exposure during the prepubertal,
activation phase, estrogens stimulate kiss1mRNAandKP
fiber density in the hypothalamus and drive GnRH neu-
rons. Here we have provided evidence that the estrogenic
mycotoxin ZEA and EE2 administered to female rats at
prepubertal ages increases kiss1 expression, enhances the
density of KP-immunoreactive fibers in the anterior hy-
pothalamus, and increases appositions between KP-con-
taining profiles and GnRH neurons similarly to changes
seen during puberty. These transcriptional changes and
Table 1. Antibody Table
Peptide/
Protein
Target
Antigen Sequence
(If Known)
Name of
Antibody
Manufacturer, Catalog
Number, and/or Name
of Individual Providing the
Antibody
Species Raised
(Monoclonal or
Polyclonal)
Dilution
Used
GnRH Mammalian GnRH conjugated
to bovine thyroglobulin
Guinea pig anti-
GnRH
Erik Hrabovszky; number 1018 Guinea pig polyclonal 1:3000
Kisspeptin Amino acids 43–52:
YNWNSFGLRY (mouse)
Rabbit a-kisspeptin Alain Caraty, number 566 rabbit polyclonal 1:10 000
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morphological rearrangements might be responsible for
the enhanced gnrh mRNA transcription and puberty ac-
celeration. Our data on the prepubertal effects of EE2 are
in contrast with data obtained by Overgaard et al (65),
who found aminor if any effect of perinatal EE2 exposure
on hypothalamic kisspeptin expression or puberty onset.
Frombirth to puberty, there is a continuous increase in the
number of KP-neurons in the AVPV region (58), and KP
action throughGPR54onGnRHneurons are essential for
triggering HPG activity. Our present study confirmed
GPR54 expression in the hypothalamus. However,
mRNA levels afterZEAandEE2 treatment did not change
in the preoptic region, whereas it increased in the ARC.
The timing of puberty onset is genetically encoded, epi-
genetically modified, influenced by stimulatory and re-
straining factors, and is very sensitive to metabolic and
environmental cues. RING finger transcription factorma-
korin 3 (MKRN 3) has recently been identified as a major
developmental restraining factor of the GnRH pulse gen-
erator (43, 66). Inmice, expressionofmkrn3mRNAin the
ARC is highest at PND 10–12 and its gradual decline
correlates with the increase of Kiss1 and Tac2 at puberty
onset (43). Two genes (eed and cbx7) of the Polycomb
group of the transcriptional silencing complex (67) have
also been recently implicated in the inhibitory control of
hypothalamic kiss1 expression and puberty (42). Because
neithermkrn3 nor eed and cbx7mRNA levels decrease in
response to xenoestrogens, it is likely that EE2 and ZEA
advance puberty by stimulating propuberty factors rather
than by inhibiting puberty restraining mechanisms.
Puberty timing depends on the metabolic status, which
is conferred byhormonal inputs (such as leptin) that signal
the energy supplies of the body (68, 69). It is not likely,
however, that ZEA and EE2 significantly affect this path-
way because these compounds did not result in overt in-
crease of white fat depots. By contrast, EE2 treatment
significantly reduced bodyweight gain, similar to that ob-
served in ovariectomized rodents after estrogen treatment
(70).
One other confounding factor would be the stress as-
sociated with the oral gavage, which has recently been
show to alter organization of the ER circuit in the limbic
system (71) and might interact with the effects of EE2 or
ZEA. However, stress in generally and stress-induced
CRH in particular delay, rather than accelerate, puberty,
as seen in xenoestrogen-treated rats.
Exposure to other endocrine disruptors, such as bis-
phenol A, genistein, diethylstilbestrol, and dichlorodiphe-
nyl-trichloroethane also affect the timing of the vaginal
opening, depending on the critical agewindow (for review
see reference 72). Furthermore, some estrogenic 1-ethyl-
3-(3-dimethylaminopropyl)-carbodiimides alter HPG
regulation through the kisspeptinergic system. For in-
stance, it has been very recently shown that the acute ad-
ministration of bisphenol A at proestrus to adult female
mice enhances positive estrogenic action and results in an
increase of KP activity and gnrh expression (73). By con-
trast, in testing of EE2 and an extensive array of pesticides
and their combination throughout gestation and lacta-
tion, Overgaard et al (65) did not find a significant effect
on kiss1 expression.
The xenoestrogen doses used in our experiments have
relevance for human exposure. The dose of EE2 corre-
sponds to a daily intake of contraceptive pills taken by
adolescent girls for birth control or for treatment of
hypogonadism.
The risk of ZEA exposure is increasing: according to a
recent analysis, 93%–96% of cereal samples have been
contaminated by ZEA in northern Europe (74). The levels
vary by country and by year, but so far, the highest ZEA
concentration, 49 mg/kg, was found in a wheat sample
from Australia (75). In a retrospective analysis of girls
involved in a school epidemic of premature thelarche in
Northern Italy, elevated serum zearalenone/zeranol con-
centrations were detected (23).
It should also be noted, however, that our data have a
number of limitations in comparison with human expo-
sure. We have used relatively high doses of xenoestrogens
and gave them for a limited time at a postnatal/peripu-
bertal age. By contrast, the population is exposed to sev-
eral compounds at low levels but sometimes for much
more prolonged (even life-long) time periods. Further-
more, it is increasingly recognized that the effect of xe-
noestrogens might be additive with other endocrine dis-
ruptive compounds. These complex interactions warrant
further studies.
In summary, our present data show that exposure of
peripubertal rats to the structurally different xenoestro-
gens EE2 and ZEA advances puberty onset, very likely by
increasing/amplifying the kisspeptinergic drive to GnRH
neurons. Because of the high probability of exposure to
xenoestrogens, one might be aware of the possible endo-
crine disruptive effects of these compounds especially in
the peripubertal life period.
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